Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis
Marine Drugs · 2025
DOI: 10.3390/md23090344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Natalia Y Anisimova und 8 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Blokhin National Medical Research Center of Oncology (N.N. Blokhin NMRCO) of the Ministry of Health of the Russian Federation, 115478 Moscow, Ru…. Hauptthemen laut MEDLINE: Chondroitin Sulfates, Hematopoiesis, Tissue Scaffolds, Absorbable Implants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The aim of this study was to evaluate the prospects of using natural fucosylated chondroitin sulfate (FCS) from the sea cucumber Cucumaria japonica as the active component of an implantable biodegradable scaffold to stimulate hematopoiesis in mice with cyclophosphamide (CPh)-induced myelosuppression. The scaffolds were based on bioresorbable Fe–Mn–C and Fe–Mn–Pd alloys after equal-channel angular pressing (ECAP). The efficiency of the developed constructs with FCS was compared with the activity of the same scaffolds loaded with recombinant human granulocyte colony stimulating factor, as well as solutions of these active compounds administered subcutaneously after the end of the cyclophosphamide (CPh) course. It was found that implantation of the Fe–Mn–C scaffold loaded with FCS most effectively stimulated hematopoiesis, providing a complex effect. This design of the developed constructs contributed to an increase in the concentration not only of leukocytes and neutrophils, but also platelets in the blood, promoted the proliferation of bone marrow cells, increasing the concentration of Ki-67(+) cells, and contributed to the restoration of the morphology of the animals’ spleen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- N.N. Blokhin National Medical Research Center of Oncology (N.N. Blokhin NMRCO) of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia.
- A.A. Baikov Institute of Metallurgy and Materials Science of the Russian Academy of Sciences, 119334 Moscow, Russia.
- P.N. Lebedev Physical Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.
- N. D. Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences, 119991 Moscow, Russia.
ORCID-Profile: Natalia Y Anisimova, Olga V Rybalchenko, Natalia S Martynenko, Nikolay E Nifantiev
Förderung
- Russian Science Foundation
Zitieren
APA
Anisimova, N. Y., Rybalchenko, O. V., Martynenko, N. S., Rybalchenko, G. V., Lukyanova, E. A., Bilan, M. I., Usov, A. I., Kiselevskiy, M. V., & Nifantiev, N. E. (2025). Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis. Marine Drugs. https://doi.org/10.3390/md23090344
Vancouver
Anisimova NY, Rybalchenko OV, Martynenko NS, Rybalchenko GV, Lukyanova EA, Bilan MI, et al. Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis. Marine Drugs. 2025. doi:10.3390/md23090344
BibTeX
@article{Anisimova2025,
author = {Anisimova, Natalia Y and Rybalchenko, Olga V and Martynenko, Natalia S and Rybalchenko, Georgy V and Lukyanova, Elena A and Bilan, Maria I and Usov, Anatolii I and Kiselevskiy, Mikhail V and Nifantiev, Nikolay E},
title = {Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23090344}
}
EUVIMED